Recurrence and variability of germline EPCAM deletions in Lynch syndrome

Human Mutation

Volumn 32, Issue 4, 2011, Pages 407-414

  Kuiper, Roland P ^a   Vissers, Lisenka E L M ^a   Venkatachalam, Ramprasath ^a   Bodmer, Danielle ^a   Hoenselaar, Eveline ^a   Goossens, Monique ^a   Haufe, Aline ^b   Kamping, Eveline ^a   Niessen, Renée C ^c   Hogervorst, Frans B L ^d   Gille, Johan J P ^e   Redeker, Bert ^f   Tops, Carli M J ^g   van Gijn, Marielle E ^h   van den Ouweland, Ans M W ⁱ   Rahner, Nils ^j   Steinke, Verena ^j   Kahl, Philip ^j   Holinski Feder, Elke ^k   Morak, Monika ^k,l   Kloor, Matthias ^m   Stemmler, Susanne ⁿ   Betz, Beate ^o   Hutter, Pierre ^p   Bunyan, David J ^q   Syngal, Sapna ^r   Culver, Julie O ^s   Graham, Tracy ^t   Chan, Tsun L ^u   Nagtegaal, Iris D ^a   van Krieken, J Han J M ^a   Schackert, Hans K ^b   Hoogerbrugge, Nicoline ^a   van Kessel, Ad Geurts ^a   Ligtenberg, Marjolijn J L ^a   more..

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁱ ERASMUS MEDICAL CENTER   (Netherlands)

^j UNIVERSITY OF BONN   (Germany)

^k LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^l Center of Medical Genetics and Primary Health Care   (Armenia)

^m UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

ⁿ RUHR UNIVERSITY BOCHUM   (Germany)

^o HEINRICH HEINE UNIVERSITY   (Germany)

^p Institut Central des Hopitaux Valaisans   (Switzerland)

^q SALISBURY DISTRICT HOSPITAL   (United Kingdom)

^r BRIGHAM AND WOMEN S HOSPITAL   (United States)

^s Department of Clinical Cancer Genetics ^*  (United States)

^t DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^u UNIVERSITY OF HONG KONG   (Hong Kong)

more..

Author keywords

Alu mediated recombination; EPCAM; Lynch syndrome; NAHR; TACSTD1

Indexed keywords

EPITHELIAL CELL ADHESION MOLECULE; PROTEIN MSH2;

3' UNTRANSLATED REGION; ALU SEQUENCE; ARTICLE; CONTROLLED STUDY; DNA METHYLATION; EPITHELIUM; EXON; GENE DELETION; GENETIC RECOMBINATION; GENETIC SCREENING; GENETIC VARIABILITY; GEOGRAPHY; GERM LINE; GERMANY; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR MECHANICS; NETHERLANDS; NUCLEOTIDE SEQUENCE; PEDIGREE ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION TERMINATION;

ANTIGENS, NEOPLASM; BASE SEQUENCE; CELL ADHESION MOLECULES; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA METHYLATION; GENETIC VARIATION; GERM-LINE MUTATION; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; MUTS HOMOLOG 2 PROTEIN; NETHERLANDS; PROMOTER REGIONS, GENETIC; RECURRENCE; SEQUENCE DELETION;

EID: 79952754996     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.21446     Document Type: Article

References (34)

1. Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomäki P, Chadwick RB, Kääriäinen H, Eskelinen M, Järvinen H, Mecklin JP, de la Chapelle A. 1998. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 338:1481-1487.
2. Barnetson RA, Tenesa A, Farrington SM, Nicholl ID, Cetnarskyj R, Porteous ME, Campbell H, Dunlop MG. 2006. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med 354:2751-2763.
3. Bastepe M, Fröhlich LF, Linglart A, Abu-Zahra HS, Tojo K, Ward LM, Jüppner H. 2005. Deletion of the NESP55 differentially methylated region causes loss of maternal GNAS imprints and pseudohypoparathyroidism type Ib. Nat Genet 37:25-27.
4. Batzer MA, Deininger PL. 2002. Alu repeats and human genomic diversity. Nat Rev Genet 3:370-379.
5. Chan TL, Yuen ST, Kong CK, Chan YW, Chan AS, Ng WF, Tsui WY, Lo MW, Tam WY, Li VS, Leung SY. 2006. Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer. Nat Genet 38:1178-1183.
6. Chotalia M, Smallwood SA, Ruf N, Dawson C, Lucifero D, Frontera M, James K, Dean W, Kelsey G. 2009. Transcription is required for establishment of germline methylation marks at imprinted genes. Genes Dev 23:105-117.
7. Franke G, Bausch B, Hoffmann MM, Cybulla M, Wilhelm C, Kohlhase J, Scherer G, Neumann HP. 2009. Alu-Alu recombination underlies the vast majority of large VHL germline deletions: molecular characterization and genotype-phenotype correlations in VHL patients. Hum Mutat 30:776-786.
8. Gazzoli I, Loda M, Garber J, Syngal S, Kolodner RD. 2002. A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor. Cancer Res 62:3925-3928.
9. Guarinos C, Castillejo A, Barberá VM, Peacute;rez-Carbonell L, Sánchez-Heras AB, Segura A, Guillén-Ponce C, Martínez-Cantó A, Castillejo MI, Egoavil CM, Jover R, Payá A, Alenda C, Soto JL. 2010. EPCAM germ line deletions as causes of Lynch syndrome in Spanish patients. J Mol Diagn 12:765-770.
10. Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Nakagawa H, Sotamaa K, Prior TW, Westman J, Panescu J, Fix D, Lockman J, Comeras I, de la Chapelle A. 2005. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352:1851-1860.
11. Hawkins PG, Santoso S, Adams C, Anest V, Morris KV. 2009. Promoter targeted small RNAs induce long-term transcriptional gene silencing in human cells. Nucleic Acids Res 37:2984-2995.
12. Hesson LB, Hitchins MP, Ward RL. 2010. Epimutations and cancer predisposition: importance and mechanisms. Curr Opin Genet Dev 20:290-298.
13. Hitchins MP, Wong JJ, Suthers G, Suter CM, Martin DI, Hawkins NJ, Ward RL. 2007. Inheritance of a cancer-associated MLH1 germ-line epimutation. N Engl J Med 356:697-705.
14. Kempers MJE, Kuiper RP, Ockeloen CW, Chappuis PO, Hutter P, Rahner N, Schackert HK, Steinke V, Holinski-Feder E, Morak M, Kloor M, Büttner R, Verwiel ETP, van Krieken JH, Nagtegaal ID, Goossens M, van der Post RS, Niessen RC, Sijmons RH, Kluijt I, Hogervorst FBL, Leter EM, Gille JJP, Aalfs CM, Redeker EJW, Hes FJ, Tops CMJ, van Nesselrooij BPM, van Gijn ME, Gómez García EB, Eccles DM, Bunyan DJ, Syngal S, Stoffel EM, Culver JO, Palomares MR, Graham T, Velsher L, Papp J, Oláh E, Chan TL, Leung SY, Geurts van Kessel A, Kiemeney LALM, Hoogerbrugge N, Ligtenberg MJL. 2011. Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. Lancet Oncol 12:49-55.
15. Kovacs ME, Papp J, Szentirmay Z, Otto S, Olah E. 2009. Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome. Hum Mutat 30:197-203.
16. Li L, McVety S, Younan R, Liang P, Du Sart D, Gordon PH, Hutter P, Hogervorst FB, Chong G, Foulkes WD. 2006. Distinct patterns of germ-line deletions in MLH1 and MSH2: the implication of Alu repetitive element in the genetic etiology of Lynch syndrome (HNPCC). Hum Mutat 27:388.
17. Ligtenberg MJL, Kuiper RP, Chan TL, Goossens M, Hebeda KM, Voorendt M, Lee TYH, Bodmer D, Hoenselaar E, Hendriks-Cornelissen SJB, Tsui WY, Kong CK, Brunner HG, Geurts van Kessel A, Yuen ST, van Krieken JH, Leung SY, Hoogerbrugge N. 2009. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1. Nat Genet 41:112-117.
18. Lynch HT, de la Chapelle A. 2003. Hereditary colorectal cancer. N Engl J Med 348:919-932.
19. McVety S, Younan R, Li L, Gordon PH, Wong N, Foulkes WD, Chong G. 2005. Novel genomic insertion-deletion in MLH1: possible mechanistic role for non-homologous end-joining DNA repair. Clin Genet 68:234-238.
20. Morak M, Schackert HK, Rahner N, Betz B, Ebert M, Walldorf C, Royer-Pokora B, Schulmann K, von Knebel-Doeberitz M, Dietmaier W, Keller G, Kerker B, Leitner G, Holinski-Feder E. 2008. Further evidence for heritability of an epimutation in one of 12 cases with MLH1 promoter methylation in blood cells clinically displaying HNPCC. Eur J Hum Genet 16:804-811.
21. Nagasaka T, Rhees J, Kloor M, Gebert J, Naomoto Y, Boland CR, Goel A. 2010. Somatic hypermethylation of MSH2 is a frequent event in Lynch Syndrome colorectal cancers. Cancer Res 70:3098-3108.
22. Niessen RC, Hofstra RM, Westers H, Ligtenberg MJ, Kooi K, Jager PO, de Groote ML, Dijkhuizen T, Olderode-Berends MJ, Hollema H, Kleibeuker JH, Sijmons RH. 2009. Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome. Genes Chromosomes Cancer 48:737-744.
23. Nordstrom-O'Brien M, van der Luijt RB, van Rooijen E, van den Ouweland AM, Majoor-Krakauer DF, Lolkema MP, van Brussel A, Voest EE, Giles RH. 2010. Genetic analysis of von Hippel-Lindau disease. Hum Mutat 31:521-537.
24. Ruivenkamp CA, van Wezel T, Zanon C, Stassen AP, Vlcek C, Csikós T, Klous AM, Tripodis N, Perrakis A, Boerrigter L, Groot PC, Lindeman J, Mooi WJ, Meijjer GA, Scholten G, Dauwerse H, Paces V, van Zandwijk N, van Ommen GJ, Demant P. 2002. Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers. Nat Genet 31:295-300.
25. Stankiewicz P, Lupski JR 2010. Structural variation in the human genome and its role in disease. Annu Rev Med 61:437-455.
26. Suter CM, Martin DI, Ward RL. 2004. Germline epimutation of MLH1 in individuals with multiple cancers. Nat Genet 36:497-501.
27. Tufarelli C, Stanley JA, Garrick D, Sharpe JA, Ayyub H, Wood WG, Higgs DR. 2003. Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease. Nat Genet 34:157-165.
28. van der Klift H, Wijnen J, Wagner A, Verkuilen P, Tops C, Otway R, Kohonen-Corish M, Vasen H, Oliani C, Barana D, Moller P, Delozier-Blanchet C, Hutter P, Foulkes W, Lynch H, Burn J, Möslein G, Fodde R. 2005. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC). Genes Chromosomes Cancer 44:123-138.
29. Venkatachalam R, Ligtenberg MJL, Hoogerbrugge N, Schackert HK, Görgens H, Hahn M-M, Kamping EJ, Vreede L, Hoenselaar E, van der Looij E, Goossens M, Churchman M, Carvajal-Carmona L, Tomlinson IPM, de Bruijn DRH, Geurts van Kessel A, Kuiper RP. 2010. Germline epigenetic silencing of the tumor suppressor gene PTPRJ in early onset familial colorectal cancer. Gastroenterology 139:1221-1224.
30. Vissers LE, Bhatt SS, Janssen IM, Xia Z, Lalani SR, Pfundt R, Derwinska K, de Vries BB, Gilissen C, Hoischen A, Nesteruk M, Wisniowiecka-Kowalnik B, Smyk M, Brunner HG, Cheung SW, van Geurts van Kessel A, Veltman JA, Stankiewicz P. 2009. Rare pathogenic microdeletions and tandem duplications are microhomology-mediated and stimulated by local genomic architecture. Hum Mol Genet 18:3579-3593.
31. Watson P, Vasen HF, Mecklin JP, Bernstein I, Aarnio M, Järvinen HJ, Myrhøj T, Sunde L, Wijnen JT, Lynch HT. 2008. The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer 123:444-449.
32. Wijnen J, van der Klift H, Vasen H, Khan PM, Menko F, Tops C, Meijers Heijboer H, Lindhout D, Møller P, Fodde R. 1998. MSH2 genomic deletions are a frequent cause of HNPCC. Nat Genet 20:326-328.
33. Winter MJ, Nagtegaal ID, van Krieken JH, Litvinov SV. 2003. The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology. Am J Pathol 163:2139-2148.
34. Yu W, Gius D, Onyango P, Muldoon-Jacobs K, Karp J, Feinberg AP, Cui H. 2008. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature 451:202-206.